Intravitreal Dexamethasone Implant in Autoimmune Retinopathy

PURPOSE: To describe the results of an intravitreal dexamethasone implant in managing autoimmune retinopathy (AIR). METHODS: Two patients affected by AIR underwent intravitreal dexamethasone implantation and were followed by ocular coherence tomography, visual fields, and electroretinography. RESULT...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordin, Fernando Longhi, Mengue, Carolina da Silva, Vilela, Manuel Augusto Pereira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081906/
https://www.ncbi.nlm.nih.gov/pubmed/37035523
http://dx.doi.org/10.1155/2023/5670538
Descripción
Sumario:PURPOSE: To describe the results of an intravitreal dexamethasone implant in managing autoimmune retinopathy (AIR). METHODS: Two patients affected by AIR underwent intravitreal dexamethasone implantation and were followed by ocular coherence tomography, visual fields, and electroretinography. RESULTS: The patients showed an interruption of the functional losses and remained stable with semestral injections. CONCLUSION: AIR is a complex condition with no standard treatment. The use of dexamethasone could be a valid option.

Ejemplares similares